Fernando S. Barbosa

Sao Paulo, RS, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Dose-response effects of multiple Ascaris suum exposures and their impact on lung protection during larval ascariasis.

Dose-response effects of multiple Ascaris suum exposures and their impact on lung protection during larval ascariasis.

Journal: PLoS neglected tropical diseases
Published: July 01, 2024

The long-lasting Ascaris suum antigens in the lungs shapes the tissue adaptation modifying the pulmonary architecture and immune response after infection in mice.

The long-lasting Ascaris suum antigens in the lungs shapes the tissue adaptation modifying the pulmonary architecture and immune response after infection in mice.

Journal: Microbial pathogenesis
Published: July 26, 2023

Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis.

Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis.

Journal: Vaccine
Published: September 27, 2022

Tissue eosinophilia correlates with mice susceptibility, granuloma formation, and damage during Toxocara canis infection.

Tissue eosinophilia correlates with mice susceptibility, granuloma formation, and damage during Toxocara canis infection.

Journal: Parasitology
Published: February 10, 2022

Nitric oxide contributes to liver inflammation and parasitic burden control in Ascaris suum infection.

Nitric oxide contributes to liver inflammation and parasitic burden control in Ascaris suum infection.

Journal: Experimental parasitology
Published: November 29, 2021

Genetic Background Affects the Mucosal Secretory IgA Levels, Parasite Burden, Lung Inflammation, and Mouse Susceptibility to Ascaris suum Infection.

Genetic Background Affects the Mucosal Secretory IgA Levels, Parasite Burden, Lung Inflammation, and Mouse Susceptibility to Ascaris suum Infection.

Journal: Infection and immunity
Published: November 22, 2021

ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection.

ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection.

Journal: Frontiers in immunology
Published: October 01, 2021

Bioaccessibility and oral immunization efficacy of a chimeric protein vaccine against Ascaris suum.

Bioaccessibility and oral immunization efficacy of a chimeric protein vaccine against Ascaris suum.

Journal: Microbes and infection
Published: May 17, 2021

Unraveling Ascaris suum experimental infection in humans.

Unraveling Ascaris suum experimental infection in humans.

Journal: Microbes and infection
Published: January 19, 2021

Eosinophils mediate SIgA production triggered by TLR2 and TLR4 to control Ascaris suum infection in mice.

Eosinophils mediate SIgA production triggered by TLR2 and TLR4 to control Ascaris suum infection in mice.

Journal: PLoS pathogens
Published: November 27, 2020

Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?

Ketamine can be produced by Pochonia chlamydosporia: an old molecule and a new anthelmintic?

Journal: Parasites & vectors
Published: July 09, 2020

IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection.

IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection.

Journal: Frontiers in immunology
Published: June 06, 2018
Showing 1-12 of 18

Last Updated: 09/26/2026